Scientists have developed a gene therapy that has the potential to reverse heart failure. The treatment, which is still in the early stages of development, has shown promising results in animal studies. The gene therapy works by increasing the production of a protein called cBIN1. cBIN1 is a master regulator that helps to keep heart muscles healthy. When cBIN1 levels are low, it can lead to heart failure. In animal studies, the gene therapy was able to restore normal heart function in pigs with induced cardiomyopathy. The treatment was also well-tolerated, with no serious side effects. The researchers are now planning to conduct clinical trials in humans. If the gene therapy is successful, it could offer a new treatment option for people with heart failure.
